Malignant neoplasms following cardiac transplantation

European Journal of Cardio-thoracic Surgery

Volumn 12, Issue 1, 1997, Pages 101-106

  Curtil, Alain ^a   Robin, Jacques ^a   Tronc, François ^a   Ninet, Jean ^a   Boissonnat, Pascale ^a   Champsaur, Gérard ^a  

^a LOUIS PRADEL HOSPITAL   (France)

Author keywords

Heart transplantation; Immunosuppression; Malignancies

Indexed keywords

LYMPHOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CIGARETTE SMOKING; FEMALE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SURGICAL RISK; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; LUNG NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SMOKING;

EID: 0030814382     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(97)00114-0     Document Type: Article

References (13)

1. Chen JN, Barr ML, Chadburn A, Frrizzera G, Schenkel FA, Sciacca RR, Reison DS, Addonizio LJ, Rose EA, Knowles DM, Michler RE. Management of lymphoproliferative disorders after cardiac transplantation. Ann Thorac Surg 1993;56:527-38.
2. Dresdale AR, Lutz S, Drost C, Levine TB, Fenn N, Paone G, Del Busto R, Silverman NA. Prospective evaluation of malignant neoplasms in cardiac transplant recipients uniformly treated with prophylactic antilymphocyte globulin. J Thorac Cardiovasc Surg 1993;106:1202-7.
3. Fleming RH, Jennison SH, Naunheim KS. Primary bronchogenic carcinoma in heart transplant recipient. Ann Thorac Surg 1994;57:1300-1.
4. Goldstein DJ, Williams DL, Oz MC, Weinberg AD, Rose EA, Michler RE. De novo solid malignancies after cardiac transplantation. Ann Thorac Surg 1995;60:1783-9.
5. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JPA. Risk of neoplasia in renal transplant patients. Lancet 1995:346:403-6.
6. Ninet J, Vigneron M, El Kirat A, Curtil A, Boissonat P, Champsaur G. Analyse des causes d'échec après transplantation cardiaque d'après une série consécutive de 91 cas. Arch Mal Coeur 1991;84:811-6.
7. Opelz G, Henderson R. Incidence of Non-Hodgkin Lymphoma in kidney and heart transplant recipients. Lancet 1995;342:1514-6
8. Orfeuvre H, Menegoz F, Lutz JM, Colonna M, Exbrayat C, Schaerer R. Données cliniques et épidémiologie descriptive du cancer bronchique primitif. Rev Mal Respir 1993;10:459-64.
9. Penn I. Epidemiology of cancer in tranplant patients. In: Touraine JL, Traeger J, Betuel H, Dubernard JM, Revillard JP, Dupuy C, editors. Cancer in Transplantation: Prevention and Treatment. Dordrecht: Kluwer, 1995: 3-15.
10. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphoma in transplant patients. Transplant Proc 1969;1:106-11.
11. Penn I. Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet 1986;162:603-10.
12. Swinnen LJ, Costanzo-Nordin MR, Fischer CG, O'Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Pifarre R, Fischer RI. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 1990;3232:1723-8.
13. Xerri L, Payan MJ, Choux R, Gros N, Hassoun J, Chamlian A, Blin D, Monties JR. An exeptional 18-year follow-up after cardiac transplantation. How can malignancies occur during immunosuppressive therapy? Cancer 1989;63:1697-9.